Entrada Therapeutics (TRDA) files $400M mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- Wall St set for higher open after tech rout; Mideast, tariffs in focus
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil retreats from above $100, still set for weekly rise on Middle East escalation
- Meta’s new seller app hits eBay where it hurts most
- Pullback in chip stocks is a buying opportunity, Citi says
Form S-3 Entrada Therapeutics,
November 6, 2025 7:41 AM EST
As filed with the Securities and Exchange Commission on November 6, 2025
Registration No. 333-
... More